Diaphragm Pacing Device Market Size, Share, Growth, and Industry Analysis, By Type (External Diaphragm Pacemaker and Diaphragm Pacemaker), By Application (SCI, ALS, and Other), Regional Insights and Forecast To 2035

• 

  Download Free Sample to learn more about this report

DIAPHRAGM PACING DEVICE MARKET OVERVIEW

The Diaphragm Pacing Device market is set to grow from USD 0.011 billion in 2025 to USD 0.012 billion in 2026, and is expected to achieve nearly USD 0.019 billion by 2035, advancing at a CAGR of 5.3% during 2025–2035.

It is a mechanical system is an option used by patients suffering with extremely critical health conditions and are one ventilators as they cannot breathe on their own. These devices helps the respiratory system of the patient to respire as if doing normally. It works part-time and full-time both.

It is also used by the patients who have chronic respiratory disorders and have weak lungs, diaphragm, and other respiratory organs. It improves their quality of life by helping them to breathe properly.

Key Findings

COVID-19 IMPACT

Market Growth Boosted by Pandemic due to Increased Chronic Illnesses

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The R&D was completely disrupted of many companies during the COVID period. This disruption led to delays and disturbance in the supply, demand and manufacturing of the companies as well. These disruptions happened to cause a chaos as the demand was high and the supply of the medical and pharmaceutical devices was under satisfactory, which in terms affected the Diaphragm Pacing Device Market growth. Health conditions all over the world were high during the pandemic which proportionally led to a hike in the shares of the medical sector. Apart from the pandemic people also suffered from various other diseases during the same period which led to the increased usage of the this device as chronic illnesses got power over humans.

LATEST TRENDS

Advanced features to Drive Market Growth

DP enhances speech, olfaction, movement, and overall quality of life. There is no longer a risk of the ventilator disconnecting and the shame associated with being dependent on a mechanical equipment. Reduction in respiratory infections and rising patient mobility are contributing factors to the external diaphragm pacemaker industry's expansion and will open up new chances for the diaphragm pacing device market throughout the projected period.

• Advanced diaphragm pacing systems now improve speech, mobility, and reduce respiratory infections in ~55% of healthcare facilities treating chronic respiratory disorders.

• External diaphragm pacemakers contribute to ~60% of total device usage, showing a growing preference for non-invasive options among patients with SCI and ALS.

Download Free Sample to learn more about this report

DIAPHRAGM PACING DEVICE MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into External Diaphragm Pacemaker and Diaphragm Pacemaker amongst which the leading segment is the External Diaphragm Pacemaker.

• External Diaphragm Pacemaker: By stimulating the phrenic nerve, which in turn causes the diaphragm to contract passively and regularly, external diaphragmatic pacing is a passive respiratory muscle exercise technique that aids in the rehabilitation of diaphragmatic dysfunction.

• Diaphragm Pacemaker: When someone with spinal cord injury uses a mechanical ventilator, diaphragm pacing can aid with breathing, speech, and overall quality of life. Possibly reducing reliance on a mechanical ventilator is possible with diaphragm pacing. You strengthen your diaphragm muscles and nerves with a lightweight, battery-operated device when you use diaphragm pacing device. You can breathe more easily as a resulting in the contraction of your diaphragm for better functioning of the respiratory system Both internal and external body components are used in diaphragm pacing device.

By Application

Based on application the global market can be categorized into SCI, ALS, and Other amongst which the leading segment is the SCI.

• SCI: Serious medical conditions like spinal cord injury (SCI) frequently leave victims severely sick and permanently disabled. It happens when the nerves that pass through the spinal cord's axons are damaged, which results in the loss of motor and sensory function below the site of the lesion. It improves the quality of life and aids in the recovery of patients who require mechanical ventilation due to speech or movement issues. 

• ALS: Breathing might become challenging when ALS weakens the muscles in the chest. As a matter of fact, respiratory issues have long been one of the main causes of death for ALS patients. Diaphragm involvement is the primary cause of frank respiratory failure in ALS patients. Early morphometric alterations in these neurons indicate that the phrenic nerve motor nuclei in the cervical spinal cord are situated in an area that is early impacted by ALS. In these situations, the main goal of diaphragm pacing is to induce muscular conditioning by utilizing the disease's diverse muscle involvement; however, other outcomes (such as enhanced lung compliance, higher alveolar ventilation, or atelectasis prevention) may also occur.

DRIVING FACTORS

Increased SCI and ALS diseases to boost the Market Growth

The primary market drivers of the worldwide diaphragm pacing device market are the rising incidence of ALS and the increasing prevalence of SCI (Spinal Cord Injuries). In addition, the global market is growing significantly due to the increasing breakthroughs in technology and the increasing number of product releases and innovations in the relevant segment. The diaphragm pacing device is driving the market because of its many advantages, which include reducing the need for mechanical ventilators and enabling patients to breathe more naturally and efficiently.

Rise in usage of Diaphragm pacing device in developing nations to expand the Market Growth

The market will rise as a result of the various uses for diaphragm pacing devices, including helping patients breathe and speak better and reducing their reliance on mechanical ventilators. The reason for the expansion of the market for external diaphragm pacemakers is due to their usage in the management of spinal cord injuries and chronic respiratory disorders which often prove life threatening. The diaphragm pacing market share is expanding because the diaphragm pacemaker always worries about power interruptions and external power sources.

• Rising incidence of spinal cord injuries (SCI) and amyotrophic lateral sclerosis (ALS) affects ~65% of patients requiring mechanical ventilation, increasing demand for diaphragm pacing devices.

• Adoption in developing nations has risen by ~40% in the past five years, driven by improved access to advanced respiratory care and rising chronic respiratory conditions.

RESTRAINING FACTOR

High Cost of Machinery to Impede Market Growth

A diaphragm pacing device is costly because it needs intricate and hefty precast components. It can take some practice to become comfortable inserting the diaphragm because some people find it difficult. If there is excessive forceful pushing, diaphragms may be forced out of position.

• Nearly 40% of potential patients cannot afford diaphragm pacing devices due to high costs and complexity, limiting market growth.

• Device installation and patient training challenges delay deployment in ~25% of hospitals, particularly in regions with limited respiratory care specialists.

• Download Free Sample to learn more about this report

•  

DIAPHRAGM PACING DEVICE MARKET REGIONAL INSIGHTS

North America to Dominate the Market due to Large Population

The market is primarily segmented into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

Due to its high disposable income, growing healthcare costs, and growing incidence of respiratory illnesses such sleep apnea, spinal cord injuries, and amyotrophic lateral sclerosis, North America leads the world market for diaphragm pacing devices. Additionally, rising patient disposable incomes and bettering healthcare costs are anticipated to support regional market expansion.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Avery Biomedical Devices (U.S.): Supplies ~35% of North American diaphragm pacing devices, with strong hospital partnerships.

• Synapse Biomedical (U.S.): Launched NeuRx DPS in March 2023, impacting ~20% of North American patient treatments.

List of Top Diaphragm Pacing Device Companies

• Avery Biomedical Devices (U.S.)
• Synapse Biomedical (U.S.)
• Atrotech (Germany)
• Arahelio (China)

INDUSTRIAL DEVELOPMENT

March 2023: In March 2023, Synapse Biomedical, Inc. launched a new device NeuRx Diaphragm Pacing System (NeuRx DPS).

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.